Literature DB >> 18534466

Infection burden for hip and knee arthroplasty in the United States.

Steven M Kurtz1, Edmund Lau, Jordana Schmier, Kevin L Ong, Ke Zhao, Javad Parvizi.   

Abstract

We quantified the current and historical incidence of periprosthetic infection associated with hip and knee arthroplasty in the United States using the Nationwide Inpatient Sample, as well as corresponding hospitalization charges and length of stay. The rate of infected knee arthroplasties was 0.92%, significantly greater than that of infected hip arthroplasties with 0.88%. Length of stay was significantly longer for infected hip (9.7 days) and knee (7.6 days) arthroplasties compared to uninfected procedures (hip, 4.3 days; knee, 3.9 days) (P < .0001). Hospitalization charges were also significantly greater for infected joint arthroplasties than for uninfected arthroplasties (hips, 1.76 times; knees, 1.52 times) (P < .0001). Urban-non-teaching hospitals experienced the highest burden of infection with 1.18% for hips and 1.26% for knees compared to rural (0.61% for hips and 0.69% for knees) and urban-teaching hospitals (0.73% for hips and 0.77% for knees). We found an increasing number of joint arthroplasties being diagnosed with periprosthetic infection.

Entities:  

Mesh:

Year:  2008        PMID: 18534466     DOI: 10.1016/j.arth.2007.10.017

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  261 in total

1.  Prevention of orthopedic device-associated osteomyelitis using oxacillin-containing biomineral-binding liposomes.

Authors:  Xin-Ming Liu; Yijia Zhang; Fu Chen; Irine Khutsishvili; Edward V Fehringer; Luis A Marky; Kenneth W Bayles; Dong Wang
Journal:  Pharm Res       Date:  2012-06-26       Impact factor: 4.200

2.  The Mark Coventry Award: diagnosis of early postoperative TKA infection using synovial fluid analysis.

Authors:  Hany Bedair; Nicholas Ting; Christina Jacovides; Arjun Saxena; Mario Moric; Javad Parvizi; Craig J Della Valle
Journal:  Clin Orthop Relat Res       Date:  2011-01       Impact factor: 4.176

3.  Mouse model of chronic post-arthroplasty infection: noninvasive in vivo bioluminescence imaging to monitor bacterial burden for long-term study.

Authors:  Jonathan R Pribaz; Nicholas M Bernthal; Fabrizio Billi; John S Cho; Romela Irene Ramos; Yi Guo; Ambrose L Cheung; Kevin P Francis; Lloyd S Miller
Journal:  J Orthop Res       Date:  2011-08-11       Impact factor: 3.494

4.  [Hip joint infections - Results of a questionnaire among 28 university orthopedic departments].

Authors:  K Anagnostakos; D Kohn
Journal:  Orthopade       Date:  2011-09       Impact factor: 1.087

5.  Postoperative antibiotic prophylaxis in total hip and knee arthroplasty: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Patrick Thornley; Nathan Evaniew; Michael Riediger; Mitchell Winemaker; Mohit Bhandari; Michelle Ghert
Journal:  CMAJ Open       Date:  2015-07-17

6.  XerC Contributes to Diverse Forms of Staphylococcus aureus Infection via agr-Dependent and agr-Independent Pathways.

Authors:  Danielle N Atwood; Karen E Beenken; Allister J Loughran; Daniel G Meeker; Tamara L Lantz; Justin W Graham; Horace J Spencer; Mark S Smeltzer
Journal:  Infect Immun       Date:  2016-03-24       Impact factor: 3.441

7.  Contamination Relative to the Activation Timing of Filtered-Exhaust Helmets.

Authors:  Andrew E Hanselman; Michael D Montague; Timothy R Murphy; Matthew J Dietz
Journal:  J Arthroplasty       Date:  2015-11-10       Impact factor: 4.757

8.  Efficacy of colistin-impregnated beads to prevent multidrug-resistant A. baumannii implant-associated osteomyelitis.

Authors:  Daniel P Crane; Kirill Gromov; Dan Li; Kjeld Søballe; Christian Wahnes; Hubert Büchner; Matthew J Hilton; Regis J O'Keefe; Clinton K Murray; Edward M Schwarz
Journal:  J Orthop Res       Date:  2009-08       Impact factor: 3.494

9.  IL-12 promotes myeloid-derived suppressor cell recruitment and bacterial persistence during Staphylococcus aureus orthopedic implant infection.

Authors:  Cortney E Heim; Debbie Vidlak; Tyler D Scherr; Curtis W Hartman; Kevin L Garvin; Tammy Kielian
Journal:  J Immunol       Date:  2015-03-11       Impact factor: 5.422

10.  Do claims-based comorbidities adequately capture case mix for surgical site infections?

Authors:  Hilal Maradit Kremers; Laura W Lewallen; Brian D Lahr; Tad M Mabry; James M Steckelberg; Daniel J Berry; Arlen D Hanssen; Elie F Berbari; Douglas R Osmon
Journal:  Clin Orthop Relat Res       Date:  2014-12-06       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.